ARCHIVES

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Funding: Shalala Approves Agreement Over Disputed $14 Million

August 8, 1997

NCI Communications Director Sieber To Retire; Science Planner Waldrop Also To Leave NCI.

September 14, 2001

Study Finds Relationship Between Meat Intake, Cancer

August 27, 2010

In Brief: NIH Reviewers, Advisors To Get Increase In Honoraria; Price Leaving NCI for Maryland

March 14, 1980

NCI Plans SBIR “Bridge” Award To Commercialize Technology.

April 11, 2008

Teddy DeVita’s Courageous Fight Ends At Age 17

June 6, 1980